Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Case Reports in Women'S Health|March 17, 2025
Isolated abdominal wall metastasis 42 years after curative surgery for ovarian cancer: A case reportRoland Csorba, Paul Buderath, Marc Ingenwerth, et al.
World Journal of Surgical Oncology|August 17, 2013
Definition of compartment-based radical surgery in uterine cancer: modified radical hysterectomy in intermediate/high-risk endometrial cancer using peritoneal mesometrial resection (PMMR) by M Höckel translated to robotic surgeryRainer Kimmig, Bahriye Aktas, Paul Buderath, et al.
ISRN Obstetrics and Gynecology|April 17, 2013
Definition of compartment based radical surgery in uterine cancer-part I: therapeutic pelvic and periaortic lymphadenectomy by Michael höckel translated to robotic surgeryRainer Kimmig, Antonella Iannaccone, Paul Buderath, et al.
World Journal of Surgical Oncology|August 27, 2013
Definition of compartment-based radical surgery in uterine cancer: radical hysterectomy in cervical cancer as 'total mesometrial resection (TMMR)' by M Höckel translated to robotic surgery (rTMMR)Rainer Kimmig, Pauline Wimberger, Paul Buderath, et al.
Archives of Gynecology and Obstetrics|August 26, 2025
Robotic-assisted surgery in extremely obese patients: a multidisciplinary approach for a patient with a BMI of 101.7 kg/m<sup>2</sup>Roland Csorba, Sàed Almasarweh, Zeynep Atas Elfrink, et al.
Future Science OA|January 25, 2017
Evaluation of a novel ELISA for the tumor-associated antigen CA 72-4 in patients with ovarian cancerPaul Buderath, Sabine Kasimir-Bauer, Bahriye Aktas, et al.
Journal of Gynecologic Oncology|December 15, 2021
Total mesometrial resection (TMMR) for cervical cancer FIGO IB-IIA: first results from the multicentric TMMR register studyPaul Buderath, Maciej Stukan, Wencke Ruhwedel, et al.
Gynecologic Oncology|May 30, 2018
ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancerLydia Giannopoulou, Sophia Mastoraki, Paul Buderath, et al.
Oncotarget|April 19, 2017
EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapyIssam Chebouti, Sabine Kasimir-Bauer, Paul Buderath, et al.
Frontiers in Oncology|November 5, 2019
Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian CancerPaul Buderath, Esther Schwich, Christina Jensen, et al.
Pageof 7